Tuesday, april 27 anatomy - Experimental Biology

tuesday
D101 978.21 Differences in the cardiac proteome in rats
selected for either low or high running capacity. J. Burniston,
J. Kenyani, J. Wastling, L. Koch and S.L. Britton. Liverpool
John Moores Univ., Sch. of Vet. Sci., Univ. of Liverpool and
Univ. of Michigan.
D102 978.22 Diosgenin supress cardiac apoptosis and
enhance survival pathway in ovariectomized rats. S-D. Lee, C-Y.
Tasi, H-C. Ou and C-Y. Huang. China Med. Univ., Taiwan.
D103 978.23 The ZDSD, a new rat model of metabolic
syndrome: evidence of cardiovascular disease. C.S. Packer,
L.M. Meulen, A.M. Boice, K. Coy and R.G. Peterson. Indiana
Univ. Sch. of Med. and PreClinOmics, Indianapolis.
D104 978.24 The ZDSD, a new rat model of metabolic
syndrome: altered arterial muscle mechanics. C.S. Packer,
A.M. Boice, L.M. Meulen, K. Coy and R.G. Peterson. Indiana
Univ. Sch. of Med. and PreClinOmics, Indianapolis.
D105 978.25 Niacin reduces renal damage and insulin
insensitivity in Charles River obese SHR (SHROB/cp): a model
of the metabolic syndrome. Y-J. Kang, T. Manero, S. Levine,
D. Owens, P. Chander and C. Stier. New York Med. Col.,
Nathan Kline Inst., Orangeburg, NY and Charles River Labs.,
Wilmington, MA.
D106 978.26 Telmisartan improves cognitive function
through the increase in neurotrophic factor and inhibition of
apoptosis in hippocampus of rats with metabolic syndrome. T.
Kishi, Y. Hirooka and K. Sunagawa. Kyushu Univ. Grad. Sch.
of Med. Sci., Japan.
979. Cerebral Circulation I
Poster
Tu e. 7:30 a m—An a h e i m Co n v e n t i o n Ce n t e r, Ex h i b it Ha l l CD
Presentation time: 12:45 p m-3:00 p m
D107 979.1 Canrenoic acid, a mineralocorticoid receptor
antagonist, attenuates resistance artery remodeling in strokeprone
spontaneous hypertensive rats. P.W. Pires, J.L. McClain
and A.M. Dorrance. Michigan State Univ.
D108 979.2 Postnatal maturation and hypoxic acclimatization
modulate PKG-mediated activation of BK channels in ovine
cerebral arteries. J.M. Williams, S.L. Stockman, T.M. Lincoln
and W.J. Pearce. Loma Linda Univ. Sch. of Med. and Univ. of
Southern Alabama Col. of Med.
D109 979.3 Involuntary breathing movements improve
cerebral oxygenation during apnea struggle phase in elite
divers. Z. Dujic, L. Uglesic, T. Breskovic, Z. Valic, K. Heusser,
J. Marinovic, M. Ljubkovic and I. Palada. Univ. of Split Sch. of
Med., Croatia and Hannover Med. Sch., Germany.
D110 979.4 Inhibition of PPARg during pregnancy causes
inward remodeling of brain parenchymal arterioles. M.J.
Cipolla, S-L. Chan, A.C. Chapman and J.A. Godfrey. Univ. of
Vermont.
D111 979.5 Role of cAMP and cGMP in arachidonic acid
and PGE2-induced cerebral vasodilation in newborn pigs.
A.J. Kanu and C.W. Leffler. Univ. of Tennessee Hlth. Sci. Ctr.,
Memphis.
D112 979.6 PPARa agonists acutely dilate the mouse
middle cerebral artery. N.K. Parelkar, M.Z. Badr and J.
Andresen. Sch. of Med. and Sch. of Pharm., Univ. of Missouri-
Kansas City.
physiology
D113 979.7 Indication for cholinergically mediated cerebral
vasodilatation during static exercise in humans. T. Seifert, J.P.
Fisher, C.N. Young, D. Hartwich, P.J. Fadel and N.H. Secher.
Univ. of Copenhagen, Sch. of Sport & Exercise Sci., Univ. of
Birmingham, UK and Univ. of Missouri-Columbia.
D114 979.8 Akt/Bcl-2 signaling is critical for anti-apoptotic
effects of carbon monoxide against TNF-alpha-mediated
inflammatory damage in cerebral vascular endothelial cells. S.
Basuroy, S. Bhattacharya, C.W. Leffler and H. Parfenova.
Univ. of Tennessee Hlth. Sci. Ctr., Memphis.
980. Coordinate Regulation of Vascular
Smooth Muscle Gene Expression, Cell
Phenotype, and Vessel Function
Poster
Tu e. 7:30 a m—An a h e i m Co n v e n t i o n Ce n t e r, Ex h i b it Ha l l CD
Presentation time: 12:45 p m-3:00 p m
D115 980.1 Cyclosporine upregulates KLF4 in vascular
smooth muscle cells and drives phenotypic modulation in vivo.
D.S. Sinden, S.M. Garvey, D.L. Rose, P.D. Schoppee Bortz,
M.Y. Lee and B.R. Wamhoff. Univ. of Virginia.
D116 980.2 Genomics approach using calcineurin/NFAT
inhibitors to identify novel effectors of vascular smooth muscle
phenotypic modulation. M.Y. Lee, S.M. Garvey and B.R.
Wamhoff. Univ. of Virginia.
D117 980.3 Sphingosine kinase 1 is required for smooth
muscle cell phenotypic modulation in response to vascular
injury. B.R. Wamhoff, T. Matthews, J. Hogan, A. Morris, Y.
Karel, T. Macdonald and K.R. Lynch. Univ of Virginia and
Univ. of Kentucky.
D118 980.4 Nuclear factor of activated T cells regulates
osteopontin expression in arterial smooth muscle in response
to diabetes-induced hyperglycemia. M.F. Gomez, L.M.
Nilsson-Berglund, A.V. Zetterqvist, J. Nilsson-Öhman, M.
Sigvardsson, L.V. Gonzalez-Bosc, M-L. Smith, A. Salehi,
E. Agardh, G. Nordin-Fredrikson, C-D. Agardh, J. Nilsson,
B.R. Wamhoff and A. Hultgårdh-Nilsson. Lund Univ. and
Linköping Univ., Sweden, Univ. of New Mexico and Univ. of
Virginia.
D119 980.5 NFAT5 positively regulates SMaA gene
expression in vascular smooth muscle. J.A. Lemmon, H.M.
Kwon and B.R. Wamhoff. Univ. of Virginia and Univ. of
Maryland Baltimore.
D120 980.6 Interference with peroxisome proliferator
activated receptor gamma in smooth muscle causes aortic
dysfunction via a Rho-kinase-dependent mechanism. C.J.
Pelham, P. Ketsawatsomkron, S. Groh, W.J. de Lange, F.M.
Faraci and C.D. Sigmund. Univ. of Iowa.
D121 980.7 In P14 rat middle cerebral arteries relations
between myogenic tone and cytosolic Ca 2+ are enhanced by
myofilament Ca 2+ sensitization and increased Ca 2+ influx, but
attenuated by high proportions of noncontractile smooth m
S.M. Charles, L. Zhang, M.J. Cipolla, J.N. Buchholz and W.J.
Pearce. Loma Linda Univ. Sch. of Med. and Univ. of Vermont
Col. of Med.
D122 980.8 Phenotypic differences between neonatal and
adult ovine carotid arteries predict reactivity to chronic hypoxia
and VEGF. O.O. Adeoye, S.M. Butler, J.M. Abrassart, E.A.
Mock, J.M. Williams and W.J. Pearce. Loma Linda Univ. Sch.
of Med.
t
u
e
301